Showing results (131-140 of 305) with videos related to
Sort By:
Pageof 31
Journal of Gerontology|July 1, 1987
Senile dementia of the Alzheimer's type: an important risk factor for serious fallsJ C Morris, E H Rubin, E J Morris, et al.Radiologie (Heidelberg, Germany)|May 7, 2024
[Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology]R Ebner, J Rübenthaler, J Ricke, et al.Gene Therapy|October 6, 2012
Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirusG K Grünwald, K Klutz, M J Willhauck, et al.Gene Therapy|April 30, 2010
A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.Annals of Neurology|July 1, 1988
Validation of clinical diagnostic criteria for Alzheimer's diseaseJ C Morris, D W McKeel, K Fulling, et al.Archives of Neurology|April 1, 1993
Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and olderL Berg, D W McKeel, J P Miller, et al.AJNR. American Journal of Neuroradiology|October 11, 2007
Neuropathology for the neuroradiologist: plaques and tanglesF J Wippold, N Cairns, K Vo, et al.Neurology|December 13, 2000
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's diseaseJ C Wang, J M Kwon, P Shah, et al.Preparative Biochemistry|January 1, 1989
Capillary zone electrophoresis separation of recombinant human interleukin-3 and related proteinsR I Hecht, J C Morris, F S Stover, et al.Cancer Gene Therapy|October 6, 2012
A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancerM A Trujillo, M J Oneal, S McDonough, et al.Pageof 31